Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage i nonseminomatous germ cell tumours: Long-term outcome and analysis of risk factors of recurrence

European Urology

Volumn 58, Issue 6, 2010, Pages 912-918

  Nicolai, Nicola ^a   Miceli, Rosalba ^a   Necchi, Andrea ^a   Biasoni, Davide ^a   Catanzaro, Mario ^a   Milani, Angelo ^a   Piva, Luigi ^a   Pizzocaro, Giorgio ^b   Stagni, Silvia ^a   Torelli, Tullio ^a   Salvioni, Roberto ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b San Giuseppe Hospital   (Italy)

Author keywords

Clinical stage I; Germ cell and embryonal; Lymph node excision; Neoplasms; Retroperitoneal space; Risk factors

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; EMBRYONAL CARCINOMA; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; RISK ASSESSMENT; TERATOMA; TREATMENT OUTCOME;

ADULT; CHEMOTHERAPY, ADJUVANT; HUMANS; ITALY; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; PATIENT SELECTION; RETROPERITONEAL SPACE; RISK ASSESSMENT; RISK FACTORS; TESTICULAR NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78049477610     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.08.032     Document Type: Article

References (31)

1. G. Read, S.P. Stenning, and M.H. Cullen Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party J Clin Oncol 10 1992 1762 1768
2. N. Nicolai, and G. Pizzocaro A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup J Urol 54 1995 1045 1049
3. C.J. Sweeney, B.P. Hermans, and D.K. Heilman Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma - predominant testis cancer J Clin Oncol 18 2000 358 362
4. A.J. Stephenson, G.J. Bosl, and R.J. Motzer Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome J Clin Oncol 20 23 2005 2781 2788
5. T.K. Choueiri, A.J. Stephenson, and T. Gilligan Management of clinical stage I nonseminomatous germ cell testicular cancer Urol Clin North Am 34 2007 137 148
6. S. Krege, J. Beyer, and R. Souchon European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I Eur Urol 53 2008 478 496
7. Y. Vergouwe, E.W. Steyerberg, and M.J. Eijkemans Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review J Clin Oncol 21 2003 4092 4099
8. M.H. Cullen, S.P. Stenning, and M.C. Parkinson Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report J Clin Oncol 14 1996 1106 1113
9. S.D. Foss, A.B. Jacobsen, and N. Aass How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources? Br J Cancer 70 1994 1156 1160
10. S.F. Brewster Challenging the EAU 2009 guidelines on testis cancer: the risk-adapted management of stage I nonseminomatous germ cell tumours: surveillance yields equal results with less toxicity Eur Urol Suppl 9 2010 459 461
11. N. Albqami, and G. Janetschek Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer J Endourol 19 2005 683 692
12. G. Pizzocaro, R. Salvioni, and N. Nicolai The role of adjuvant treatment in low-stage germ cell testicular tumors Eur Urol 28 1995 267 272
13. N. Nicolai, R. Miceli, and R. Artusi A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only J Urol 171 2004 172 176
14. G. Pizzocaro Retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germinal testis cancer Eur J Surg Oncol 12 1986 25 28 (Pubitemid 16042181)
15. S. Durrleman, and R. Simon Flexible regression models with cubic splines Stat Med 8 1989 551 561
16. T.G. Clark, and D.G. Altman Developing a prognostic model in the presence of missing data: an ovarian cancer case study J Clin Epidemiol 56 2003 28 37
17. F.E. Harrell, K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
18. B. Efron, and R.J. Tibshirani An introduction to the bootstrap 1993 Chapman and Hall New York, NY
19. Van Buuren S, Oudshoorn CGM. Multivariate imputation by chained equations: MICE v.1.0 user's manual. TNO Report PG/VGZ/00.038, 2000. Multiple Imputation Online Web site. http://www.multiple-imputation.com/. Accessed October 13, 2008.
20. J.P. Donohue, J.A. Thornhill, and R.S. Foster Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-1989 Br J Urol 71 1993 326 335
21. A.J. Stephenson, G.J. Bosl, and R.J. Motzer Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer J Clin Oncol 25 2007 5597 5602
22. P. Albers, R. Siener, and S. Krege Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group J Clin Oncol 26 2008 2966 2972
23. T. Tandstad, O. Dahl, and G. Cohn-Cedermark Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA Management Program J Clin Oncol 27 2009 2122 2128
24. C. Kollmannsberger, C. Moore, and K.N. Chi Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy Ann Oncol 21 2010 1296 1301
25. D.J. Brenner, R. Doll, and D.T. Goodhead Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know Proc Natl Acad Sci U S A 100 2003 13761 13766
26. H.Y. Yu, R.A. Madison, and C.M. Setodji Quality of surveillance for stage I testis cancer in the community J Clin Oncol 27 2009 4327 4332
27. O. Klepp, A.M. Olsson, and H. Henrikson Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group J Clin Oncol 8 1990 509 518
28. O. Klepp, O. Dahl, and P. Flodgren Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer Eur J Cancer 33 1997 1038 1044
29. J. Sheinfeld, and R.J. Motzer Stage I testicular cancer management and necessity for surgical expertise J Clin Oncol 26 2008 2944 2946
30. A.W. van den Belt-Dusebout, R. de Wit, and J.A. Gietema Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer J Clin Oncol 25 2007 4370 4378
31. C.T. Nguyen, A.Z. Fu, and T.D. Gilligan Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis J Clin Oncol 28 2010 119 125